Barbian, Hannah J.
Kittner, Alyse
Teran, Richard
Bobrovska, Sofiya
Qiu, Xueting
English, Kayla
Green, Stefan J.
Ghinai, Isaac
Pacilli, Massimo
Hayden, Mary K.
Funding for this research was provided by:
Centers for Disease Control and Prevention
Article History
Received: 27 July 2023
Accepted: 19 December 2023
First Online: 2 January 2024
Declarations
:
: Methods were in accordance with relevant regulations and guidelines. The study protocol was reviewed and determined to not meet the definition of human subjects research and was exempt from ethical approval by the Rush University Institutional Review Board. All submitted samples were de-identified and all analyses were performed on de-identified sequences and sample metadata. Informed consent for specimen collection was waived because collection was part of a public health response by the Chicago Department of Public Health under regulation 45 CFR 46.102(I)(2).
: Not applicable.
: MKH was a member of a clinical adjudication panel for an investigational SARS-CoV-2 vaccine produced by Sanofi. All other authors report no competing interests.